[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356478-105":59,"doc-detail-356478-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multi-omics-study-on-tumor-associated-macrophages-remodeling-the-tumor-microenvironment-via-the-cxcl5-cxcr2-axis-to-drive-immune-escape-in-bladder-cancer","Multi-omics study on tumor-associated macrophages remodeling the tumor microenvironment via the CXCL5-CXCR2 axis to drive immune escape in bladder cancer","","Background PD-1/L1 inhibitors improve outcomes in advanced bladder cancer, yet remission remains under 25%, with resistance mechanisms unresolved. Tumor-associated macrophages and chemokines critically shape the tumor microenvironment, influencing tumor growth, immunotherapy response, and patient prognosis, but their interaction mechanisms remain unclear. This study investigates bladder cancer cell–TAM interactions and factors determining immunotherapy efficacy using a tumor microenvironment perspective.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-study-on-tumor-associated-macrophages-remodeling-the-tumor-microenvironment-via-the-cxcl5-cxcr2-axis-to-drive-immune-escape-in-bladder-cancer/356478/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-study-on-tumor-associated-macrophages-remodeling-the-tumor-microenvironment-via-the-cxcl5-cxcr2-axis-to-drive-immune-escape-in-bladder-cancer/356478.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in bladder cancer immunotherapy?","Question",{"text":112,"@type":113},"The study targets the low clinical remission rate of PD-1/L1 inhibitors and the unclear mechanisms behind resistance in advanced bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which tumor microenvironment mechanism is highlighted in the results?",{"text":117,"@type":113},"The study identifies the CXCL5-CXCR2 axis, acting through NF-κB, as a driver of PD-L1 upregulation and an immunosuppressive tumor microenvironment.",{"name":119,"@type":110,"acceptedAnswer":120},"How does the CXCL5-CXCR2 axis affect immunotherapy efficacy?",{"text":121,"@type":113},"It enhances IDO1 expression in macrophages and improves immunotherapy efficacy, while TAM subsets show distinct relationships with survival and immune response.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356478,1790737453,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Immunology, Immunotherapy (2026) 75:103  \n[https://doi.org/10.1007/s00262-026-04353-8](https://doi.org/10.1007/s00262-026-04353-8)  \nMulti‑omics study on tumor‑associated macrophages remodeling the tumor microenvironment via the CXCL5‑CXCR2 axis to drive immune escape in bladder cancer  \nYunzhong Jiang1 · Jianpeng Li2 · Zezhong Yang1 · Minghai Ma3 · Lu Wang4 · Lu Zhang5 · Minxuan Jing1 · Yaodong Zhang1 · Yuanchun Pu1 · Yutong Chen1 · Jiale He1 · Hang Liu1 · Xiaowei Qu6 · Mengzhao Zhang7 · Jinhai Fan1  \nReceived: 18 October 2025 / Accepted: 25 February 2026 © The Author(s) 2026  \nAbstract  \nBackground PD-1/L1 inhibitors improve the prognosis of patients with advanced bladder cancer, but the clinical remission rate remains below 25% . Tumor-associated macrophages (TAMs) and chemokines are critical in the tumor microenvironment (TME), affecting tumor progression, immunotherapeutic efficacy, and patient prognosis; however, their underlying mechanisms remain unclear. This study exhibits innovation by adopting a tumor microenvironment perspective to investigate the interaction mechanism between bladder cancer cells and tumor-associated macrophages, as well as factors affecting the efficacy of immunotherapy.  \nMethods Single-cell sequencing, bulk sequencing, and in vivo experiments identified TAM infiltration characteristics, their impacts on prognosis and immunotherapy. In vitro, we established a co-culture model and performed targeted metabolomic sequencing on TAMs. Xenograft and tail vein metastasis models were used to investigate the function of CXCL5-CXCR2 axis in bladder TME.  \nResults M2 macrophages were positively correlated with the clinical staging of bladder cancer and resistance to immunotherapy. Single-cell sequencing data revealed that CXCL5+ tumor-associated macrophages (TAMs) were associated with poor overall survival but a favorable response to immunotherapy, whereas FOLR2+ TAMs were linked to both poor overall survival and immunotherapy resistance. The CXCL5-CXCR2-NF-κB axis was upregulated in the co-culture system, which promoted PD-L1 expression in both tumor cells and TAMs, the formation of an immunosuppressive tumor microenvironment (TME), as well as the migration, proliferation, and lung metastatic potential of bladder cancer cells. Additionally, this axis enhanced IDO1 expression in macrophages and improved the efficacy of immunotherapy for bladder cancer.  \nConclusion The CXCL5-CXCR2 axis mediates bladder cancer cell-macrophage crosstalk: macrophages promote tumor growth, immune escape, and cisplatin tolerance; tumor cells induce macrophage polarization and reshape immunosuppressive TME. Additionally, this axis drives bladder cancer malignant progression and enhances immunotherapy efficacy.  \nKeywords Tumor-associated macrophage · CXCL5–CXCR2 · PD-L1 · Immune escape  \nIntroduction  \nThe incidence rate of bladder cancer is 9.5 per 100,000 person-years for men and 2.4 for women [1] . Non-muscleinvasive and muscle-invasive bladder cancer are the two primary pathological types. Muscle-invasive bladder cancer is  \nYunzhong Jiang, Jianpeng Li and Zezhong Yang have contributed equally to this work.  \nExtended author information available on the last page of the article  \ncharacterized by a high recurrence rate and poor prognosis [2] . PD-1/L1 inhibitors have been demonstrated to improve the prognosis of patients with advanced bladder cancer. Targeting PD-1/L1 via immunotherapy undoubtedly offers new hope to these patients [3] . However, the clinical remission rate with immunotherapy is less than 25%[4], and the mechanism of resistance to immunotherapy remains poorly understood. The expression of PD-L1 is a key factor influencing the efficacy of immunotherapy. Nonetheless, studies have indicated that patients with low PD-L1 expression can also respond to immunotherapy, making it controversial  \nwhether PD-L1 expression levels influence the efficacy of immunotherapy [5, 6] .  \nAn accumulating body of studies ha","cbCaia1pJvC7kNbC","https://ap.wps.com/l/cbCaia1pJvC7kNbC","pdf",13134378,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Bladder cancer burden and PD-1/L1 immunotherapy\n## Tumor-associated macrophages in the tumor microenvironment\n## Chemokines and CXCL family signaling","[{\"question\":\"What problem does the study address in bladder cancer immunotherapy?\",\"answer\":\"The study targets the low clinical remission rate of PD-1/L1 inhibitors and the unclear mechanisms behind resistance in advanced bladder cancer.\"},{\"question\":\"Which tumor microenvironment mechanism is highlighted in the results?\",\"answer\":\"The study identifies the CXCL5-CXCR2 axis, acting through NF-κB, as a driver of PD-L1 upregulation and an immunosuppressive tumor microenvironment.\"},{\"question\":\"How does the CXCL5-CXCR2 axis affect immunotherapy efficacy?\",\"answer\":\"It enhances IDO1 expression in macrophages and improves immunotherapy efficacy, while TAM subsets show distinct relationships with survival and immune response.\"}]","Multi-omics study on tumor-associated macrophages remodeling the tumor microenvironment via the CXCL5-CXCR2 axis to drive immune escape in bladder cancer | PDF",1790125510,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71c80891a2346a2ef1e84125a2147af1.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4105d43eafde10ec7a313d705cdb00c2.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03c2a174eae1001654d499632e4ebb99.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53a578be7f71eefa73e56fa45082c577.webp",980,1301]